Improving malaria control in West Africa: Interruption of transmission as a paradigm shift

Acta Tropica

Volumn 121, Issue 3, 2012, Pages 175-183

  Doumbia, Seydou O ^a   Ndiaye, Daouda ^b   Koita, Ousmane A ^a   Diakité, Mahamadou ^a   Nwakanma, Davis ^c   Coulibaly, Mamadou ^a   Traoré, Sekou F ^a   Keating, Joseph ^d   Milner, Danny A ^e   Ndiaye, Jean Louis ^b   Sene, Papa Diogoye ^b   Ahouidi, Ambroise ^b   Dieye, Tandakha N ^b   Gaye, Oumar ^b   Okebe, Joseph ^c   Ceesay, Serign J ^c   Ngwa, Alfred ^c   Oriero, Eniyou C ^c   Konaté, Lassana ^b   Sy, Ngayo ^b   Jawara, Musa ^c   Faye, Ousmane ^b   Kéita, Moussa ^a   Cissé, Moussa ^a   Sogoba, Nafomon ^a   Poudiougou, Belco ^a   Diawara, Sory ^a   Sangaré, Lansana ^a   Coulibaly, Tinzana ^a   Seck, Ibrahima ^b   Abubakar, Ismaela ^c   Gomis, Jules ^b   Mather, Frances J ^d   Sissako, Aliou ^a   Diarra, Ayouba ^a   Kandeh, Balla ^f   Whalen, Christopher ^g   Moyer, Brian ^g   Nnedu, Obinna ^d   Thiero, Oumar ^a   Bei, Amy K ^e   Daniels, Rachel ^e   Miura, Kazutoyo ^h   Long, Carole A ^h   Fairhurst, Rick M ^h   Duraisingh, Manoj ^e   Muskavitch, Marc A T ⁱ   D'Alessandro, Umberto ^c   Conway, David J ^c,j   Volkman, Sarah K ^e   Valim, Clarissa ^e   Wirth, Dyann F ^e   Krogstad, Donald J ^d   more..

^a UNIVERSITY OF BAMAKO   (Mali)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^d TULANE UNIVERSITY   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f The National Malaria Control Programmes   (Gambia)

^g Research Data   (United States)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁱ BOSTON COLLEGE   (United States)

^j LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

Malaria control; Paradigm shift; Plasmodium falciparum; Population based data

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ANTIMALARIAL AGENT; ARSUCAM; ARTEMETHER PLUS BENFLUMETOL; DIHYDROARTEMISININ PLUS PIPERAQUINE; DUO COTECXIN; HEMOGLOBIN; UNCLASSIFIED DRUG;

CHILD HEALTH; DISEASE CONTROL; DISEASE PREVALENCE; DISEASE TRANSMISSION; IMMUNE RESPONSE; INFECTIOUS DISEASE; MALARIA; MORBIDITY; MORTALITY; PARADIGM SHIFT;

AFRICA; ANOPHELES; ARTICLE; BIOSTATISTICS; BLOOD SMEAR; CELLULAR IMMUNITY; CLINICAL PROTOCOL; DIAGNOSTIC TEST; DISEASE TRANSMISSION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FINANCIAL MANAGEMENT; HUMAN; HUMORAL IMMUNITY; INCIDENCE; INFECTION CONTROL; INFORMATION TECHNOLOGY; INTERVENTION STUDY; MALARIA; MEDICAL RECORD; MORBIDITY; MORTALITY; PARASITEMIA; PATHOGENESIS; PLASMODIUM FALCIPARUM; POPULATION RESEARCH; PREVALENCE; SAMPLE SIZE; TELECOMMUNICATION;

AFRICA, WESTERN; ANIMALS; ANOPHELES; ANTIBODIES, PROTOZOAN; ANTIMALARIALS; COMMUNICABLE DISEASE CONTROL; DISEASE TRANSMISSION, INFECTIOUS; DRUG RESISTANCE, MICROBIAL; GENOTYPE; HUMANS; IMMUNITY, CELLULAR; INCIDENCE; MALARIA, FALCIPARUM; NATIONAL HEALTH PROGRAMS; PARASITEMIA; PLASMODIUM FALCIPARUM; PREVALENCE; SEASONS; SENSITIVITY AND SPECIFICITY;

WEST AFRICA;

PLASMODIUM FALCIPARUM;

EID: 84857655355     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2011.11.009     Document Type: Article

References (47)

1. Águas R., White L.J., Snow R.W., Gomes M.G.M. Prospects for malaria eradication in sub-Saharan Africa. PLoS ONE 2008, 3(3):e1767.
2. Ajuwon G.A., Rhine L. The level of Internet access and ICT training for health professionals in sub-Saharan Africa. Health Info. Libr. J. 2008, 25(3):174-185.
3. Atieli F.K., Munga S.O., Ofulla A.V., Vulule J.M. The effect of repeated washing of long-lasting insecticide-treated nets (LLINs) on the feeding success and survival rates of Anopheles gambiae. Malar. J. 2010, 9:304.
4. Bates A.H., Jiang H., Fairhurst R.M., Su X.-Z. Use of magnetically purified Plasmodium falciparum parasites improves the accuracy of erythrocyte invasion assays. Exp. Parasitol. 2010, 126(2):278-280.
5. Biggs B.A., Kemp D.J., Brown G.V. Subtelomeric chromosome deletions in field isolates of Plasmodium falciparum and their relationship to loss of cytoadherence in vitro. Proc. Natl. Acad. Sci. U.S.A. 1989, 86(7):2428-2432.
6. Bisoffi Z., Sirima S.B., Menten J., Pattaro C., Angheben A., Gobbi F., Tinto H., Lodesani C., Neya B., Gobo M., Van den Ende J. Accuracy of a rapid diagnostic test on the diagnosis of malaria infection and of malaria-attributable fever during low and high transmission season in Burkina Faso. Malar. J. 2010, 9:192.
7. Bojang K., Milligan P., Pinder M., Doherty T., Leach A., Ofori-Anyinam O., Lievens M., Kester K., Schaecher K., Ballou W.R., Cohen J. Five year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia. Hum Vacc. 2009, 5(4):242-247.
8. Bountogo M., Zoungrana A., Coulibaly B., Kose C., Mansmann U., Mockenhaupt F.P., Burhenne J., Mikus G., Walter-Sack I., Schirmer R.H., Sie A., Meissner P., Muller O. Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated Plasmodium falciparum malaria: a controlled trial in Burkina Faso. Trop. Med. Int. Health 2010, 15(6):713-717.
9. Breman J.G., Alilio M.S., Mills A. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. Am. J. Trop. Med. Hyg. 2004, 71(2 Suppl.):1-15.
10. Carter R., Mendis K.N. Evolutionary and historical aspects of the burden of malaria. Clin. Microbiol. Rev. 2002, 15:564-594.
11. Ceesay S.J., Casals-Pascual C., Erskine J., Anya S.E., Duah N.O., Fulford A.J.C., Sesay S.S.S., Abubakar I., Dunyo S., Sey O., Palmer A., Fofana M., Corrah T., Bojang K.A., Whittle H.C., Greenwood B.M., Conway D.J. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet 2008, 372(9649):1545-1554.
12. Cholera R., Brittain N.J., Gillrie M.R., Lopera-Mesa T.M., Diakite S.A., Arie T., Krause M.A., Guindo A., Tubman A., Fujioka H., Diallo D.A., Doumbo O.K., Ho M., Wellems T.E., Fairhurst R.M. Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(3):991-996.
13. Cohen J.M., Moonen B., Snow R.W., Smith D.L. How absolute is zero? An evaluation of historical and current definitions of malaria elimination. Malar. J. 2010, 9:213.
14. Colborn J.M., Koita O.A., Cissé O.H., Bagayoko M.W., Guthrie E.J., Krogstad D.J. Identifying and quantifying genotypes in polyclonal infections due to single species. Emerg. Infect. Dis. 2005, 12(3):475-482.
15. Coulibaly M.B., Pombi M., Caputo B., Nwakanma D., Jawara M., Konaté L., Dia I., Fofana A., Kern M., Simard F., Conway D.J., Petrarca V., della Torre A., Traoré S.F., Besansky N.J. PCR-based karyotyping of Anopheles gambiae inversion 2Rj identifies the BAMAKO chromosomal form. Malar. J. 2007, 6:133.
16. Daniels R., Volkman S.K., Milner D.A., Mahesh N., Neafsey D.E., Park D.J., Rosen D.R., Angelino E., Sabeti P.C., Wirth D.F., Wiegand R.C. A general SNP-based molecular barcode for P. falciparum identification and tracking. Malar. J. 2008, 7:223.
17. Dharia N.V., Sidhu A.B., Cassera M.B., Westenberger S.J., Bopp S.E., Eastman R.T., Plouffe D., Batalov S., Park D.J., Volkman S.K., Wirth D.F., Zhou Y., Fidock D.A., Winzeler E.A. Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum. Genome Biol. 2009, 10(2):R21.
18. Feachem R.G.A., Phillips A.A., Hwang J., Cotter C., Wielgosz B., Greenwood B.M., Sabot O., Rodriguez M.H., Abeyasinghe R.R., Ghebreyesus T.A., Snow R.W. Malaria elimination. 1. Shrinking the malaria map: progress and prospects. Lancet 2010, 376(9752):1566-1578.
19. Food and Drug Administration, 2007. Guidance for industry, malaria: developing drug and nonvaccine biological products for treatment and prophylaxis, (accessed October 16, 2011). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071951.pdf.
20. Gamboa D., Ho M.-F., Bendezu J., Torres K., Chiodine P.L., Barnwell J.W., Incardona S., Perkins M., Bell D., McCarthy J., Cheng Q. A large proportion of P. falciparum isolates in the American region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS ONE 2010, 5(1):e8091.
21. Google Apps for Higher Education (Universities and Colleges). (accessed April 5, 2011). http://www.google.com/a/help/intl/ened/university.html.
22. Greenwood B.M. Can malaria be eliminated?. Trans. R. Soc. Trop. Med. Hyg. 2009, 103(Suppl. 1):S2-S5.
23. Griffing S.M., Mixson-Hayden T., Sridaran S., Alam M.T., McCollum A.M., Cabezas C., Quezeda W.M., Barnwell J.W., De Oliveira A.M., Lucas C., Arrospide N., Escalante A.A., Bacon D.J., Udhayakumar V. South American Plasmodium falciparum after the malaria eradication era: clonal population expansion and survival of the fittest hybrids. PLoS ONE 2011, 6(9):e23486.
24. Hay S.I., Smith D.L., Snow R.W. Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect. Dis. 2008, 8(6):369-378.
25. Kelly-Hope L.A., McKenzie F.E. The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa. Malar. J. 2009, 8:19.
26. Kemp D.J., Walliker Thompson J.K.D., Corcoran L.M. Molecular karyotype of Plasmodium falciparum: conserved linkage groups and expendable histidine-rich protein genes. Proc. Natl. Acad. Sci. U.S.A. 1987, 84(21):7672-7676.
27. Koita, O.A., Doumbo, O.K., Ouattara, A., Tall, L.K., Konaré, A., Diakité, M., Diallo, M., Sagara, I., Masinde, G.L., Doumbo, S.N., Dolo, A., Tounkara, A., Traoré, I., Krogstad, D.J. False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene. Am. J. Trop. Med. Hyg., in press.
28. Mendis K., Rietveld A., Warsame M., Bosman A., Greenwood B.M., Wernsdorfer W.H. From malaria control to eradication: the WHO perspective. Trop. Med. Int. Health 2009, 14(7):802-809.
29. Miura K., Orcutt A.C., Muratova O.V., Miller L.H., Saul A., Long C.A. Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines. Vaccine 2008, 26(2):193-200.
30. Nahlen B.L., Low-Beer D. Building to collective impact: the Global Fund support for measuring reduction in the burden of malaria. Am. J. Trop. Med. Hyg. 2007, 77(Suppl. 6):321-327.
31. Ndiaye D., Patel V., Demas A., LeRoux M., Ndir O., Mboup S., Clardy J., Lakshmanan V., Daily J.P., Wirth D.F. A non-radioactive DAPI-based high-throughput in vitro assay to assess Plasmodium falciparum responsiveness to antimalarials-increased sensitivity of P. falciparum to chloroquine in Senegal. Am. J. Trop. Med. Hyg. 2010, 82(2):228-230.
32. Ndiaye J.-L., Randrianarivelojosia M., Sagara I., Brasseur P., Ndiaye I., Faye B., Randrianasolo L., Ratsimbasoa A., Forlemu D., Moor V.A., Traoré A., Dicko Y., Dara N., Lameyre V., Diallo M., Djimde A., Same-Ekobo A., Gaye O. Randomized, multicenter assessment of the efficacy and safety of ASAQ-a fixed dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Malar. J. 2009, 8:125.
33. O'Meara W.P., Mangeni J.N., Steketee R.W., Greenwood B.M. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect. Dis. 2010, 10(8):545-555.
34. Pampana, E.J., 1969. A Textbook of Malaria Eradication, second edition. Oxford, London, pp. 1-510.
35. Pologe L.G., Ravetch J.V. A chromosomal rearrangement in a P. falciparum histidine-rich protein gene is associated with the knobless phenotype. Nature 1986, 322(6078):433-477.
36. Riehle M.M., Guelbeogo W.M., Gneme A., Eiglmeier K., Holm I., Bischoff E., Garnier T., Snyder G.M., Li X., Markianos K., Sagnon N.-F., Vernick K.D. A cryptic subgroup of Anopheles gambiae is highly susceptible to human malaria parasites. Science 2011, 331(6017):596-598.
37. Rowe A.K. Potential of integrated continuous surveys and quality management to support monitoring, evaluation, and the scale-up of health interventions in developing countries. Am. J. Trop. Med. Hyg. 2009, 80(6):971-979.
38. Satoguina J., Walther B., Drakeley C., Nwakanma D., Oriero E.C., Correa S., Corran P., Conway D.J., Walther M. Comparison of surveillance methods applied to a situation of low malaria prevalence at rural sites in The Gambia. Malar. J. 2009, 8:274.
39. Smith H., Bukirwa H., Mukasa O., Snell P., Adeh-Nsoh S., Mbuyita S., Honorati M., Orji B., Garner P. Access to electronic health knowledge in five countries in Africa: a descriptive study. BMC Health Serv. Res. 2007, 7:72.
40. Sogoba N., Vounatsou P., Bagayoko M.M., Doumbia S.O., Dolo G., Gosoniu L., Traoré S.F., Smith T.A., Touré Y.T. Spatial distribution of the chromosomal forms of Anopheles gambiae in Mali. Malar. J. 2008, 7:205.
41. Tanner M., de Savigny D. Malaria eradication back on the table. Bull. WHO 2008, 86(2):82-83.
42. Traoré B., Kone Y., Doumbo S., Doumtabe D., Traoré A., Crompton P.D., Mircetic M., Huang C.Y., Kayentao K., Dicko A., Ellis R.D., Miura K., Guindo A., Miller L.H., Doumbo O.K., Pierce S.K. The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali. Vaccine 2009, 27(52):7299-7303.
43. Tshefu A.K., Gaye O., Kayentao K., Thompson R., Bhatt K.M., Sesay S.S.S., Bustos D.G., Tjitra E., Bedu-Addo G., Borghini-Fuhrer I., Duparc S., Shin C.K., Fleckenstein L. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomized non-inferiority trial. Lancet 2010, 375(9724):1457-1467. the Pyronaridine-artesunate Study Team.
44. Volkman S.K., Sabeti P.C., DeCaprio D., Neafsey D.W., Schaffner S.F., Milner D.A., Daily J.P., Sarr O., Ndiaye D., Ndir O., Mboup S., Duraisingh M.T., Lukens A., Derr A., Stange-Thomann N., Waggoner S., Onofrio R., Mauceli E., Gnerre S., Jaffe D.B., Zainoun J., Wiegand R.C., Birren B.W., Hartl D.L., Galagan J.E., Lander E.S., Wirth D.F. A genome-wide map of diversity in Plasmodium falciparum. Nat. Gen. 2007, 39(1):113-119.
45. + T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathogens 2009, 3:e1000364.
46. Wellems T.E., Hayton K., Fairhurst R.M. The impact of malaria parasitism: from corpuscles to communities. J. Clin. Invest. 2009, 119(9):2496-2505.
47. World Health Organization, 2006. Global Malaria Programme Indoor Residual Spraying. WHO position statement. Available at: (accessed August 4, 2008). http://www.who.int/malaria/docs/IRS/IRS-position.pdf.